Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Ovarian neoplasm
ADR ID BADD_A05940
ADR Hierarchy
16      Neoplasms benign, malignant and unspecified (incl cysts and polyps)
16.12      Reproductive neoplasms female malignant and unspecified
16.12.06      Female reproductive neoplasms unspecified malignancy
16.12.06.001      Ovarian neoplasm
21      Reproductive system and breast disorders
21.11      Ovarian and fallopian tube disorders
21.11.01      Ovarian and fallopian tube cysts and neoplasms
21.11.01.005      Ovarian neoplasm
Description Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS. [MeSH]
MedDRA Code 10061535
MeSH ID D010051; D013330
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Neoplasm of uncertain behavior of ovary | Neoplasm of uncertain behaviour of ovary | Ovarian neoplasia | Ovarian neoplasm NOS | Ovarian neoplasm | Struma ovarii | Ovarian Neoplasms | Neoplasm, Ovarian | Ovarian Neoplasm | Ovary Neoplasms | Neoplasm, Ovary | Neoplasms, Ovary | Ovary Neoplasm | Neoplasms, Ovarian | Ovary Cancer | Cancer, Ovary | Cancers, Ovary | Ovary Cancers | Ovarian Cancer | Cancer, Ovarian | Cancers, Ovarian | Ovarian Cancers | Cancer of Ovary | Cancer of the Ovary
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00066Alendronic acid0.000044%
BADD_D00457Choriogonadotropin alfa--
BADD_D00954Follitropin alfa--
BADD_D00955Follitropin beta--
BADD_D01036Gonadorelin--
BADD_D01281Levonorgestrel0.000946%
BADD_D01332Lutropin alfa--
BADD_D01380Menotropins--
BADD_D02236Tofacitinib0.000241%
BADD_D02319Urofollitropin--
BADD_D02412Octreotide--
BADD_D02464Fingolimod0.000241%
The 1th Page    1    Total 1 Pages